ATLASEdesa Biotech (EDSA) earnings date: Dec 11, 2026
Edesa Biotech (EDSA) reports earnings for the quarter ended Sep 30, 2026 on Fri, Dec 11, 2026. Analysts expect EPS of -$0.57.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on EDSA
| Last price | $2.60 (+1.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.1% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Edesa Biotech stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Edesa Biotech reports on Dec 11, 2026. One email the day before, with ATLAS’s read on Edesa Biotech. You can switch it off at any time.
Alert me before EDSA reportsFree to start. Creating an account takes under a minute.
Notify me when Edesa Biotech reports
Track EDSA free Add Edesa Biotech to a free ATLAS watchlist and see its next report date in one place.
EDSA earnings at a glance
| Next report (confirmed) | Fri, Dec 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.57 |
| Last report | Aug 13, 2026 · Miss |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -19.6% |
| Average move around a report | ±5.1% (last 4) |
| Sector | Healthcare · Biotechnology |
Edesa Biotech earnings history: last 4 reports
Edesa Biotech last reported on Aug 13, 2026: EPS of -$0.60 against an estimate of -$0.43 (-39.5% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.43 | -$0.60 | -39.5% | Miss | +0.9% |
| May 14, 2026 | -$0.26 | -$0.49 | -88.5% | Miss | -14.4% |
| Feb 13, 2026 | -$0.45 | -$0.28 | +37.8% | Beat | +3.0% |
| Jan 13, 2026 | $1.36 | $1.52 | +11.8% | Beat | -2.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for EDSA
See the fair value, the probability range and the earnings history of Edesa Biotech on its ATLAS page.
Edesa Biotech (EDSA) stock analysisPlans from €3.99 a month.
Edesa Biotech earnings: frequently asked questions
When does Edesa Biotech (EDSA) report earnings?
Edesa Biotech is scheduled to report on Friday, December 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for EDSA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.57 per share (USD). Estimates can change before the report.
How often does EDSA beat earnings estimates?
Of its last 4 reports with a recorded result, Edesa Biotech beat the EPS estimate 2 times; the average surprise was -19.6%. Past results do not predict the next one.
How much does EDSA move around earnings?
Over its last 4 reports the stock moved an average of 5.1% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Edesa Biotech beat earnings estimates last quarter?
Edesa Biotech last reported on Aug 13, 2026: EPS of -$0.60 against an estimate of -$0.43 (-39.5% surprise), a miss.
How much does EDSA usually move in a day?
On a normal trading day the ATLAS model puts EDSA’s one-day range at about ±5.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Dec 11, 2026
Educational information, not investment advice. Disclaimer